0 Day Left

Biomedical Catalyst 2022 Round 1: Industry-led R&D

Fund Name

Biomedical Catalyst 2022 Round 1: Industry-led R&D

Project Length

6-36 months

Project Value

£150k-£4m

Deadline

25.05.2022

Apply Now

Innovate UK, part of UK Research and Innovation will invest up to £15 million in projects to support UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes.

Check Your Eligibility

Fund Details

The aim of this industry-led R&D competition is to support the development of innovative solutions to health and healthcare challenges.

Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures
  • the development of digital health technologies

The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

Innovate UK will only support innovation projects conducted to the highest standards of animal welfare.

Your project can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Specific Themes

The Biomedical Catalyst now incorporates the Digital Health Technology Catalyst and will support digital health projects.

Your project can align with one or more of the following Innovation areas:

  • biosciences
  • advanced therapies (gene and cell therapies)
  • diagnostic, medical technology and devices
  • digital health
  • independent living and wellbeing
  • precision medicine
  • preclinical technologies and drug target discovery
  • therapeutic and medicine development

Eligibility

Your project

Your project must:

  • have total project costs between £150,000 and £4 million
  • not exceed a grant request of £2 million
  • have at least 50% of the total project costs shared by the SMEs, if collaborative
  • start by 1 December 2022
  • end by 30 November 2025
  • last between 6 months and 36 months
  • carry out all of its project work in the UK
  • intend to exploit the results from or in the UK

To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME).

Talk to us today if you would like to apply for this opportunity.

Apply Now